- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tibet Rhodiola Pharmaceutical Holding Co (600211)
Tibet Rhodiola Pharmaceutical Holding Co stock price live, this page displays SS 600211 stock exchange data. View the 600211 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tibet Rhodiola Pharmaceutical Holding Co real time stock price chart below.
What Is the Tibet Rhodiola Pharmaceutical Holding Co Stock Price Today?
The Tibet Rhodiola Pharmaceutical Holding Co stock price today is 46.95.
What Is the Stock Symbol for Tibet Rhodiola Pharmaceutical Holding Co?
The stock symbol for Tibet Rhodiola Pharmaceutical Holding Co is ""600211.""
What Stock Exchange Does Tibet Rhodiola Pharmaceutical Holding Co Trade On?
Tibet Rhodiola Pharmaceutical Holding Co is listed and trades on the Shanghai stock exchange.
Is Tibet Rhodiola Pharmaceutical Holding Co a Good Stock to Buy?
Determining whether Tibet Rhodiola Pharmaceutical Holding Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600211 quote. (ISIN: CNE000000ZW7)
What Is the Tibet Rhodiola Pharmaceutical Holding Co Stock Price Today?
The Tibet Rhodiola Pharmaceutical Holding Co stock price today is 46.95.
What Is the Stock Symbol for Tibet Rhodiola Pharmaceutical Holding Co?
The stock symbol for Tibet Rhodiola Pharmaceutical Holding Co is ""600211.""
What Stock Exchange Does Tibet Rhodiola Pharmaceutical Holding Co Trade On?
Tibet Rhodiola Pharmaceutical Holding Co is listed and trades on the Shanghai stock exchange.
Is Tibet Rhodiola Pharmaceutical Holding Co a Good Stock to Buy?
Determining whether Tibet Rhodiola Pharmaceutical Holding Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600211 quote. (ISIN: CNE000000ZW7)
Shanghai
Currency in CNY
46.95
+0.85(+1.84%)
Closed·
Fair Value
An estimate of a Tibet Rhodiola Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
45.99
47.63
52 wk Range
31.30
51.35
600211 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
1/3
Fair Value
An estimate of a Tibet Rhodiola Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
45.9947.63
52 wk Range
31.3051.35
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.17%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.17%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600211 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Tibet Rhodiola Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy
Tibet Rhodiola Pharmaceutical Holding Co Company Profile
Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceuticals in China and internationally. The company offers biological products, tibetan medicine, chinese medicine, and chemical medicine products. It also offers capsules, preparations, granules, and coatings for cardiovascular, cerebrovascular, hepatobiliary, sprains and contusions, rheumatism, rheumatoid arthritis, colds, etc. Tibet Rhodiola Pharmaceutical Holding Co. was founded in 1999 and is based in Lhasa, China.
Compare 600211 to Peers and Sector
Metrics to compare | 600211 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600211PeersSector | |
|---|---|---|---|---|
P/E Ratio | 15.0x | 15.3x | −0.5x | |
PEG Ratio | 0.61 | −0.61 | 0.00 | |
Price/Book | 3.7x | 1.0x | 2.6x | |
Price / LTM Sales | 5.4x | 0.6x | 3.3x | |
Upside (Analyst Target) | - | 16.3% | 40.1% | |
Fair Value Upside | Unlock | 22.4% | 5.1% | Unlock |
Earnings
Latest Release
Aug 16, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Tibet Rhodiola Pharm Trade On?
Tibet Rhodiola Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.
What Is the Stock Symbol for Tibet Rhodiola Pharm?
The stock symbol for Tibet Rhodiola Pharm is "600211."
What Is the Tibet Rhodiola Pharm Market Cap?
As of today, Tibet Rhodiola Pharm market cap is 15.13B.
What Is Tibet Rhodiola Pharm's Earnings Per Share (TTM)?
The Tibet Rhodiola Pharm EPS (TTM) is 3.13.
When Is the Next Tibet Rhodiola Pharm Earnings Date?
Tibet Rhodiola Pharm will release its next earnings report on 23 Oct 2025.
From a Technical Analysis Perspective, Is 600211 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Tibet Rhodiola Pharm Stock Split?
Tibet Rhodiola Pharm has split 4 times.
How Many Employees Does Tibet Rhodiola Pharm Have?
Tibet Rhodiola Pharm has 596 employees.
What is the current trading status of Tibet Rhodiola Pharm (600211)?
As of 17 Aug 2025, Tibet Rhodiola Pharm (600211) is trading at a price of 46.95, with a previous close of 46.10. The stock has fluctuated within a day range of 45.99 to 47.63, while its 52-week range spans from 31.30 to 51.35.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.